Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +520 | +8.61% | $0.00 | 6.56K | Sep 1, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$71K | -180 | -2.74% | $394.60 | 6.38K | Sep 1, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +405 | +6.35% | $0.00 | 6.79K | Sep 1, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$55.6K | -141 | -2.08% | $394.60 | 6.64K | Sep 1, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +433 | +6.52% | $0.00 | 7.08K | Sep 2, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$59.2K | -150 | -2.12% | $394.60 | 6.93K | Sep 2, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +557 | +8.04% | $0.00 | 7.48K | Sep 3, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$79.7K | -202 | -2.7% | $394.60 | 7.28K | Sep 3, 2023 | Direct | |
transaction | BIO | Bio-Rad A Common Stock | Options Exercise | $0 | +600 | +8.24% | $0.00 | 7.88K | Sep 4, 2023 | Direct | F1 |
transaction | BIO | Bio-Rad A Common Stock | Tax liability | -$118K | -298 | -3.78% | $394.60 | 7.58K | Sep 4, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BIO | Restricted Stock Units | Award | $0 | +3.01K | $0.00 | 3.01K | Sep 1, 2023 | Bio-Rad A Common Stock | 3.01K | $0.00 | Direct | F2, F3 | |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -520 | -24.98% | $0.00 | 1.56K | Sep 1, 2023 | Bio-Rad A Common Stock | 520 | $0.00 | Direct | F2, F4 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -405 | -33.31% | $0.00 | 811 | Sep 1, 2023 | Bio-Rad A Common Stock | 405 | $0.00 | Direct | F2, F5 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -433 | -49.94% | $0.00 | 434 | Sep 2, 2023 | Bio-Rad A Common Stock | 433 | $0.00 | Direct | F2, F6 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -557 | -50% | $0.00 | 557 | Sep 3, 2023 | Bio-Rad A Common Stock | 557 | $0.00 | Direct | F2, F7 |
transaction | BIO | Restricted Stock Units | Options Exercise | $0 | -600 | -100% | $0.00* | 0 | Sep 4, 2023 | Bio-Rad A Common Stock | 600 | $0.00 | Direct | F2, F8 |
Id | Content |
---|---|
F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
F3 | The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
F4 | On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F5 | On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F6 | On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
F7 | On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
F8 | On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |